Hyojin Ko

3.1k total citations · 1 hit paper
62 papers, 2.5k citations indexed

About

Hyojin Ko is a scholar working on Physiology, Organic Chemistry and Molecular Biology. According to data from OpenAlex, Hyojin Ko has authored 62 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Physiology, 23 papers in Organic Chemistry and 21 papers in Molecular Biology. Recurrent topics in Hyojin Ko's work include Adenosine and Purinergic Signaling (24 papers), Pharmacological Receptor Mechanisms and Effects (7 papers) and Synthesis and Biological Evaluation (6 papers). Hyojin Ko is often cited by papers focused on Adenosine and Purinergic Signaling (24 papers), Pharmacological Receptor Mechanisms and Effects (7 papers) and Synthesis and Biological Evaluation (6 papers). Hyojin Ko collaborates with scholars based in South Korea, United States and Japan. Hyojin Ko's co-authors include Sanghee Kim, Kenneth A. Jacobson, T. Kendall Harden, Samad Ahadian, Ali Khademhosseini, Kwanwoo Shin, Hossein Montazerian, Nureddin Ashammakhi, Natan Roberto de Barros and Deukjoon Kim and has published in prestigious journals such as Advanced Materials, Hepatology and Advanced Drug Delivery Reviews.

In The Last Decade

Hyojin Ko

61 papers receiving 2.5k citations

Hit Papers

Bioinks and bioprinting technologies to make heterogeneou... 2019 2026 2021 2023 2019 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hyojin Ko South Korea 28 864 725 587 575 254 62 2.5k
Ziling Zeng China 30 2.5k 2.9× 1.1k 1.6× 155 0.3× 49 0.1× 381 1.5× 57 3.9k
Xuan Wang China 34 1.2k 1.4× 1.0k 1.4× 279 0.5× 57 0.1× 431 1.7× 156 3.8k
Laura R. Saunders United States 19 366 0.4× 1.9k 2.6× 135 0.2× 105 0.2× 290 1.1× 40 3.7k
Hea Ok Kim South Korea 29 221 0.3× 1.2k 1.6× 1.1k 1.8× 760 1.3× 276 1.1× 97 2.5k
Shuo Wang China 27 351 0.4× 1.2k 1.6× 79 0.1× 44 0.1× 256 1.0× 138 2.7k
Yi Zhao China 36 598 0.7× 1.4k 2.0× 138 0.2× 55 0.1× 322 1.3× 108 3.2k
Xia Cao China 35 1.0k 1.2× 1.4k 2.0× 88 0.1× 19 0.0× 473 1.9× 125 3.7k
Han Chang Kang South Korea 37 1.1k 1.2× 2.1k 2.9× 322 0.5× 46 0.1× 729 2.9× 135 4.2k
Xiaoshuang Wang China 28 860 1.0× 549 0.8× 70 0.1× 40 0.1× 219 0.9× 81 2.4k

Countries citing papers authored by Hyojin Ko

Since Specialization
Citations

This map shows the geographic impact of Hyojin Ko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hyojin Ko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hyojin Ko more than expected).

Fields of papers citing papers by Hyojin Ko

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hyojin Ko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hyojin Ko. The network helps show where Hyojin Ko may publish in the future.

Co-authorship network of co-authors of Hyojin Ko

This figure shows the co-authorship network connecting the top 25 collaborators of Hyojin Ko. A scholar is included among the top collaborators of Hyojin Ko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hyojin Ko. Hyojin Ko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ashammakhi, Nureddin, Samad Ahadian, C. F. Xu, et al.. (2019). Bioinks and bioprinting technologies to make heterogeneous and biomimetic tissue constructs. Materials Today Bio. 1. 100008–100008. 421 indexed citations breakdown →
2.
Ashtari, Khadijeh, Hojjatollah Nazari, Hyojin Ko, et al.. (2019). Electrically conductive nanomaterials for cardiac tissue engineering. Advanced Drug Delivery Reviews. 144. 162–179. 166 indexed citations
3.
Shin, S. H., Ji-Hyun Lee, Jin‐Kyoung Shim, et al.. (2018). Synthesis and structure-activity relationships of quinolinone and quinoline-based P2X7 receptor antagonists and their anti-sphere formation activities in glioblastoma cells. European Journal of Medicinal Chemistry. 151. 462–481. 25 indexed citations
4.
Lee, Sun‐Mi, Hyo‐Jeong Lee, Ji Won Kim, et al.. (2016). The discovery of 2,5-isomers of triazole-pyrrolopyrimidine as selective Janus kinase 2 (JAK2) inhibitors versus JAK1 and JAK3. Bioorganic & Medicinal Chemistry. 24(21). 5036–5046. 18 indexed citations
5.
Kim, Bo-Kyoung, et al.. (2016). 2,3,4-Trihydroxybenzyl-hydrazide analogues as novel potent coxsackievirus B3 3C protease inhibitors. European Journal of Medicinal Chemistry. 120. 202–216. 16 indexed citations
6.
Lee, Won‐Gil, et al.. (2015). Discovery of novel purine-based heterocyclic P2X7 receptor antagonists. Bioorganic Chemistry. 61. 58–65. 2 indexed citations
7.
Ko, Hyojin, et al.. (2013). Analysis of Thickness of a Hydrophobic Fluoropolymer Film Based on Electrowetting. Journal of Biomedical Nanotechnology. 9(7). 1250–1253. 1 indexed citations
8.
Bae, Jung Yoon, Doo Young Lee, Hyun Ju You, et al.. (2013). RUNX3 confers sensitivity to pheophorbide a-photodynamic therapy in human oral squamous cell carcinoma cell lines. Lasers in Medical Science. 30(2). 499–507. 10 indexed citations
9.
Jung, Kwan‐Young, et al.. (2013). Design and synthesis of potent and selective P2X3 receptor antagonists derived from PPADS as potential pain modulators. European Journal of Medicinal Chemistry. 70. 811–830. 15 indexed citations
10.
You, Hyun Ju, Hyo‐Eun Yoon, Jung‐Hoon Yoon, Hyojin Ko, & Yong‐Chul Kim. (2011). Synthesis of pheophorbide-a conjugates with anticancer drugs as potential cancer diagnostic and therapeutic agents. Bioorganic & Medicinal Chemistry. 19(18). 5383–5391. 26 indexed citations
11.
Jeong, Won‐Il, Ogyi Park, Yang‐Gun Suh, et al.. (2011). Suppression of innate immunity (natural killer cell/interferon-γ) in the advanced stages of liver fibrosis in mice. Hepatology. 53(4). 1373–1382. 123 indexed citations
12.
You, Hyun Ju, Hyung‐Seop Youn, Isak Im, et al.. (2011). Design, synthesis and X-ray crystallographic study of NAmPRTase inhibitors as anti-cancer agents. European Journal of Medicinal Chemistry. 46(4). 1153–1164. 12 indexed citations
13.
Calenbergh, Serge Van, Bhalchandra V. Joshi, Hyojin Ko, et al.. (2009). Synthesis and P2Y receptor activity of nucleoside 5′-phosphonate derivatives. Bioorganic & Medicinal Chemistry Letters. 19(11). 3002–3005. 18 indexed citations
14.
Ko, Hyojin, Arijit Das, Rhonda L. Carter, et al.. (2009). Molecular recognition in the P2Y14 receptor: Probing the structurally permissive terminal sugar moiety of uridine-5′-diphosphoglucose. Bioorganic & Medicinal Chemistry. 17(14). 5298–5311. 32 indexed citations
15.
Carter, Rhonda L., Ingrid Fricks, Matthew O. Barrett, et al.. (2009). Quantification of Gi-Mediated Inhibition of Adenylyl Cyclase Activity Reveals That UDP Is a Potent Agonist of the Human P2Y14 Receptor. Molecular Pharmacology. 76(6). 1341–1348. 70 indexed citations
16.
Jacobson, Kenneth A., Andrei A. Ivanov, Sonia de Castro, T. Kendall Harden, & Hyojin Ko. (2008). Development of selective agonists and antagonists of P2Y receptors. Purinergic Signalling. 5(1). 75–89. 100 indexed citations
17.
Ko, Hyojin, Rhonda L. Carter, Riccardo Petrelli, et al.. (2008). Synthesis and potency of novel uracil nucleotides and derivatives as P2Y2 and P2Y6 receptor agonists. Bioorganic & Medicinal Chemistry. 16(12). 6319–6332. 63 indexed citations
18.
Ko, Hyojin, Ingrid Fricks, Andrei A. Ivanov, T. Kendall Harden, & Kenneth A. Jacobson. (2007). Structure−Activity Relationship of Uridine 5‘-Diphosphoglucose Analogues as Agonists of the Human P2Y14 Receptor. Journal of Medicinal Chemistry. 50(9). 2030–2039. 55 indexed citations
19.
Jacobson, Kenneth A., Stefano Costanzi, Bhalchandra V. Joshi, et al.. (2006). Agonists and Antagonists for P2 Receptors. Novartis Foundation symposium. 276. 58–72. 44 indexed citations
20.
Lee, Sang Kook, Hye‐Young Min, Eun Young Kim, et al.. (2003). Synthesis and evaluation of cytotoxicity of stilbene analogues. Archives of Pharmacal Research. 26(4). 253–257. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026